Risk Factors for Epidemic Cholera in Lusaka, Zambia-2017.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 28 5 2020
medline: 11 11 2020
entrez: 28 5 2020
Statut: ppublish

Résumé

On October 6, 2017, the Zambia Ministry of Health declared a cholera outbreak in Lusaka. By December, 1,462 cases and 38 deaths had occurred (case fatality rate, 2.6%). We conducted a case-control study to identify risk factors and inform interventions. A case was any person with acute watery diarrhea (≥ 3 loose stools in 24 hours) admitted to a cholera treatment center in Lusaka from December 16 to 21, 2017. Controls were neighbors without diarrhea during the same time period. Up to two controls were matched to each case by age-group (1-4, 5-17, and ≥ 18 years) and neighborhood. Surveyors interviewed cases and controls, tested free chlorine residual (FCR) in stored water, and observed the presence of soap in the home. Conditional logistic regression was used to generate matched odds ratios (mORs) based on subdistricts and age-groups with 95% CIs. We enrolled 82 cases and 132 controls. Stored water in 71% of case homes had an FCR > 0.2 mg/L. In multivariable analyses, those who drank borehole water (mOR = 2.4, CI: 1.1-5.6), had close contact with a cholera case (mOR = 6.2, CI: 2.5-15), and were male (mOR = 2.5, CI: 1.4-5.0) had higher odds of being a cholera case than their matched controls. Based on these findings, we recommended health education about household water chlorination and hygiene in the home. Emergency responses included providing chlorinated water through emergency tanks and maintaining adequate FCR levels through close monitoring of water sources.

Identifiants

pubmed: 32458780
doi: 10.4269/ajtmh.20-0089
pmc: PMC7410454
pii: tpmd200089
doi:
pii:

Substances chimiques

Drinking Water 0
Soaps 0
Chlorine 4R7X1O2820

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

646-651

Références

PLoS Negl Trop Dis. 2018 Apr 9;12(4):e0006379
pubmed: 29630632
Emerg Infect Dis. 2011 Nov;17(11):2143-6
pubmed: 22099120
Am J Trop Med Hyg. 2008 Sep;79(3):414-21
pubmed: 18784235
J Infect Dis. 2018 Aug 24;218(7):1164-1168
pubmed: 29757428
Am J Trop Med Hyg. 2017 Jun;96(6):1382-1387
pubmed: 28719281
MMWR Morb Mortal Wkly Rep. 2004 Sep 3;53(34):783-6
pubmed: 15343144
Lancet. 2017 Sep 23;390(10101):1539-1549
pubmed: 28302312
Curr Environ Health Rep. 2015 Mar;2(1):69-74
pubmed: 26231243
Water Res. 2015 Apr 1;72:51-63
pubmed: 25172215
MMWR Morb Mortal Wkly Rep. 2018 May 18;67(19):556-559
pubmed: 29771877
Am J Trop Med Hyg. 2018 Aug;99(2):534-545
pubmed: 29968551
Am J Trop Med Hyg. 2014 Oct;91(4):738-42
pubmed: 25114012
Am J Trop Med Hyg. 2013 Oct;89(4):654-664
pubmed: 24106192
Nat Rev Microbiol. 2009 Oct;7(10):693-702
pubmed: 19756008
Lancet. 2017 Feb 4;389(10068):547-558
pubmed: 27760703
Am J Trop Med Hyg. 2019 Jun;100(6):1335-1341
pubmed: 31017078
Int J Epidemiol. 2016 Dec 1;45(6):2134-2139
pubmed: 27789673
Epidemiol Infect. 2006 Dec;134(6):1226-30
pubmed: 16623992
East Afr Med J. 2013 Oct;90(10):324-31
pubmed: 26862642
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3314
pubmed: 25411971
Emerg Infect Dis. 2017 Dec;23(13):
pubmed: 29155665
Lancet. 1984 Feb 11;1(8372):325-8
pubmed: 6141390
PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832
pubmed: 26043000
J Infect Dis. 2018 Oct 15;218(suppl_3):S147-S153
pubmed: 30215739

Auteurs

Francis H Nanzaluka (FH)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

William W Davis (WW)

4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Lwito Mutale (L)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

Fred Kapaya (F)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

Patrick Sakubita (P)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

Nelia Langa (N)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

Angela Gama (A)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

Hammad S N'cho (HS)

4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Warren Malambo (W)

3Zambia Field Epidemiology Training Program, Lusaka, Zambia.
4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Jennifer Murphy (J)

4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Anna Blackstock (A)

4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Eric Mintz (E)

4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Margaret Riggs (M)

5U.S. Centers for Disease Control and Prevention, Lusaka, Zambia.

Victor Mukonka (V)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
6School of Medicine, Copperbelt University, Lusaka, Zambia.

Nyambe Sinyange (N)

1Ministry of Health, Lusaka, Zambia.
2Zambia National Public Health Institute, Lusaka, Zambia.
3Zambia Field Epidemiology Training Program, Lusaka, Zambia.

Ellen Yard (E)

3Zambia Field Epidemiology Training Program, Lusaka, Zambia.
5U.S. Centers for Disease Control and Prevention, Lusaka, Zambia.

Joan Brunkard (J)

4U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH